Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Vincent

Showing results (511-520 of 1,192) with videos related to

Pageof 120
Sort By:
Acta Physiologica Scandinavica|December 1, 1981
Immunohistochemical evidence for a "neurotoxic" action of (D-Pro2, D-Trp7,9)-substance P, an analogue with substance P antagonistic activityT Hökfelt, S Vincent, L Hellsten, et al.
International Journal of Sports Medicine|March 21, 2009
Athletic performance and weight changes during the "Marathon of Sands" in athletes well-trained in enduranceH Zouhal, C Groussard, S Vincent, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|November 7, 2009
Peripheral peptide YY inhibits propulsive colonic motor function through Y2 receptor in conscious miceLixin Wang, Guillaume Gourcerol, Pu-Qing Yuan, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1993
Teicoplanin-resistant Staphylococcus aureus expresses a novel membrane protein and increases expression of penicillin-binding protein 2 complexD M Shlaes, J H Shlaes, S Vincent, et al.
Blood|November 21, 2012
Improving overall survival and overcoming adverse prognosis in the treatment of cytogenetically high-risk multiple myelomaP Leif Bergsagel, María-Victoria Mateos, Norma C Gutierrez, et al.
Blood Cancer Journal|February 16, 2023
Artificial intelligence-enabled screening strategy for drug repurposing in monoclonal gammopathy of undetermined significanceAlexander J Ryu, Shaji Kumar, Angela Dispenzieri, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 26, 2015
Bortezomib-induced acute interstitial nephritisWisit Cheungpasitporn, Nelson Leung, S Vincent Rajkumar, et al.
Cancer|February 28, 2009
The treatment of multiple myeloma using vincristine, carmustine, melphalan, cyclophosphamide, and prednisone (VBMCP) alternating with high-dose cyclophosphamide and alpha(2)beta interferon versus VBMCP: results of a phase III Eastern Cooperative Oncology Group Study E5A93Robert A Kyle, Susanna Jacobus, William R Friedenberg, et al.
International Journal of Sports Medicine|August 8, 2002
Training status (endurance or sprint) and catecholamine response to the Wingate-test in womenC Jacob, H Zouhal, S Vincent, et al.
Plos One|November 28, 2012
Anti-myeloma activity of Akt inhibition is linked to the activation status of PI3K/Akt and MEK/ERK pathwayVijay Ramakrishnan, Teresa Kimlinger, Jessica Haug, et al.
Pageof 120

Showing results (511-520 of 1,192) with videos related to

Sort By:
Pageof 120
Acta Physiologica Scandinavica|December 1, 1981
Immunohistochemical evidence for a "neurotoxic" action of (D-Pro2, D-Trp7,9)-substance P, an analogue with substance P antagonistic activityT Hökfelt, S Vincent, L Hellsten, et al.
International Journal of Sports Medicine|March 21, 2009
Athletic performance and weight changes during the "Marathon of Sands" in athletes well-trained in enduranceH Zouhal, C Groussard, S Vincent, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|November 7, 2009
Peripheral peptide YY inhibits propulsive colonic motor function through Y2 receptor in conscious miceLixin Wang, Guillaume Gourcerol, Pu-Qing Yuan, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1993
Teicoplanin-resistant Staphylococcus aureus expresses a novel membrane protein and increases expression of penicillin-binding protein 2 complexD M Shlaes, J H Shlaes, S Vincent, et al.
Blood|November 21, 2012
Improving overall survival and overcoming adverse prognosis in the treatment of cytogenetically high-risk multiple myelomaP Leif Bergsagel, María-Victoria Mateos, Norma C Gutierrez, et al.
Blood Cancer Journal|February 16, 2023
Artificial intelligence-enabled screening strategy for drug repurposing in monoclonal gammopathy of undetermined significanceAlexander J Ryu, Shaji Kumar, Angela Dispenzieri, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 26, 2015
Bortezomib-induced acute interstitial nephritisWisit Cheungpasitporn, Nelson Leung, S Vincent Rajkumar, et al.
Cancer|February 28, 2009
The treatment of multiple myeloma using vincristine, carmustine, melphalan, cyclophosphamide, and prednisone (VBMCP) alternating with high-dose cyclophosphamide and alpha(2)beta interferon versus VBMCP: results of a phase III Eastern Cooperative Oncology Group Study E5A93Robert A Kyle, Susanna Jacobus, William R Friedenberg, et al.
International Journal of Sports Medicine|August 8, 2002
Training status (endurance or sprint) and catecholamine response to the Wingate-test in womenC Jacob, H Zouhal, S Vincent, et al.
Plos One|November 28, 2012
Anti-myeloma activity of Akt inhibition is linked to the activation status of PI3K/Akt and MEK/ERK pathwayVijay Ramakrishnan, Teresa Kimlinger, Jessica Haug, et al.
Pageof 120